{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:12:15Z","timestamp":1790467935948,"version":"4.1.0"},"reference-count":39,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Comprehensive data on emerging invasive fungal infections (EIFIs) in the critically ill are scarce. We conducted a case-control study to characterize EIFIs in patients admitted to a French medical ICU teaching hospital from 2006 to 2019. Among 6900 patients, 26 (4 per 1000) had an EIFI: Mucorales accounted for half, and other isolates were mainly Saprochaete, Fusarium and Scedosporium. EIFIs occurred mostly in patients with immunosuppression and severe critical illness. Antifungal treatments (mainly amphotericin B) were administered to almost all patients, whereas only 19% had surgery. In-ICU, mortality was high (77%) and associated with previous conditions such as hematological malignancy or cancer, malnutrition, chronic kidney disease and occurrence of acute respiratory distress syndrome and\/or hepatic dysfunction. Day-90 survival rates, calculated by the Kaplan\u2013Meier method, were similar between patients with EIFIs and a control group of patients with aspergillosis: 20%, 95% CI (9- 45) versus 18%, 95% CI (8- 45) (log-rank: p &gt; 0.99). ICU management of such patients should be assessed on the basis of underlying conditions, reversibility and acute event severity rather than the mold species.<\/jats:p>","DOI":"10.3390\/jof7050330","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T21:49:20Z","timestamp":1619300960000},"page":"330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-0901","authenticated-orcid":false,"given":"Romaric","family":"Larcher","sequence":"first","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"},{"name":"PhyMedExp, INSERM (French Institute of Health and Medical Research), CNRS (French National Centre for Scientific Research), University of Montpellier, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Platon","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Amalric","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Brunot","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemie","family":"Besnard","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Racim","family":"Benomar","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Daubin","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[{"name":"Hematology Department, Saint Eloi Hospital, Montpellier University Hospital, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rispail","sequence":"additional","affiliation":[{"name":"Mycology and Parasitology Laboratory, Lapeyronie Hospital, Montpellier University Hospital, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lachaud","sequence":"additional","affiliation":[{"name":"Mycology and Parasitology Laboratory, Lapeyronie Hospital, Montpellier University Hospital, 34090 Montpellier, France"},{"name":"MiVEGEC (Infectious Diseases and Vectors: Ecology, Genetic, Evolution and Control), IRD (Research and Development Institute), CNRS, University of Montpellier, 911 Avenue Agropolis, 34394 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Mycology and Parasitology Laboratory, Lapeyronie Hospital, Montpellier University Hospital, 34090 Montpellier, France"},{"name":"MiVEGEC (Infectious Diseases and Vectors: Ecology, Genetic, Evolution and Control), IRD (Research and Development Institute), CNRS, University of Montpellier, 911 Avenue Agropolis, 34394 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kada","family":"Klouche","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier University Hospital, 371, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France"},{"name":"PhyMedExp, INSERM (French Institute of Health and Medical Research), CNRS (French National Centre for Scientific Research), University of Montpellier, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and Invasive Mould Diseases in Non-Neutropenic Critically Ill Patients and Patients with Haematological Cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The Antifungal Arsenal: Alternative Drugs and Future Targets","volume":"51","author":"Wiederhold","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/1469-0691.12563","article-title":"Epidemiology of Mucormycosis in Europe","volume":"20","author":"Petrikkos","year":"2014","journal-title":"Clin. Microbiol. Infect"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/myc.12318","article-title":"Epidemiology and Outcomes of Invasive Fungal Infections in Allogeneic Haematopoietic Stem Cell Transplant Recipients in the Era of Antifungal Prophylaxis: A Single-Centre Study with Focus on Emerging Pathogens","volume":"58","author":"Satlin","year":"2015","journal-title":"Mycoses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13613-020-00673-9","article-title":"Mucormycosis in Intensive Care Unit: Surgery Is a Major Prognostic Factor in Patients with Hematological Malignancy","volume":"10","author":"Claustre","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cornely, O.A., Alastruey-Izquierdo, A., Arenz, D., Chen, S.C.A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H.E., Lagrou, K., and Lewis, R.E. (2019). Global Guideline for the Diagnosis and Management of Mucormycosis: An Initiative of the European Confederation of Medical Mycology in Cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect. Dis.","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a Combined Comorbidity Index","volume":"47","author":"Charlson","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"ref_11","first-page":"32","article-title":"GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community","volume":"43","author":"Jensen","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A New Simplified Acute Physiology Score (SAPS II) Based on a European\/North American Multicenter Study","volume":"270","author":"Gall","year":"1993","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-Related Organ Failure Assessment) Score to Describe Organ Dysfunction\/Failure. On Behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_15","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","author":"Khwaja","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"ref_16","unstructured":"ARDS Definition Task Force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., Fan, E., Camporota, L., and Slutsky, A.S. (2012). Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA, 307, 2526\u20132533."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"European Confederation of Medical Mycology ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Rare Invasive Yeast Infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin. Microbiol. Infect"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1469-0691.12515","article-title":"ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Systemic Phaeohyphomycosis: Diseases Caused by Black Fungi","volume":"20","author":"Chowdhary","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID\u2020 and ECMM\u2021 Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0039-3400957","article-title":"Phaeohyphomycosis","volume":"41","author":"Arcobello","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jac\/dkz568","article-title":"MIC Distributions for Amphotericin B, Fluconazole, Itraconazole, Voriconazole, Flucytosine and Anidulafungin and 35 Uncommon Pathogenic Yeast Species from the UK Determined Using the CLSI Broth Microdilution Method","volume":"75","author":"Borman","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-021-00818-4","article-title":"Poor Outcome Associated with Mucormycosis in Critically Ill Hematological Patients: Results of a Multicenter Study","volume":"11","author":"Jestin","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_26","unstructured":"Schmidt, M., Schellongowski, P., Patroniti, N., Taccone, F.S., Reis Miranda, D., Reuter, J., Prodanovic, H., Pierrot, M., Dorget, A., and Park, S. (2018). Six-Month Outcome of Immunocompromised Severe ARDS Patients Rescued by ECMO. An International Multicenter Retrospective Study. Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Platon, L., Amigues, L., Ceballos, P., Fegueux, N., Daubin, D., Besnard, N., Larcher, R., Landreau, L., Agostini, C., and Machado, S. (2015). A Reappraisal of ICU and Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Patients and Reassessment of Prognosis Factors: Results of a 5-Year Cohort Study (2009\u20132013). Bone Marrow Transpl.","DOI":"10.1038\/bmt.2015.269"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcrc.2006.03.006","article-title":"Isolation of Aspergillus in Critically Ill Patients: A Potential Marker of Poor Outcome","volume":"21","author":"Khasawneh","year":"2006","journal-title":"J. Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/myc.12954","article-title":"Cut It out! Thoracic Surgeon\u2019s Approach to Pulmonary Mucormycosis and the Role of Surgical Resection in Survival","volume":"62","author":"Multani","year":"2019","journal-title":"Mycoses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"892","DOI":"10.21037\/jtd.2019.01.75","article-title":"Factors Affecting Surgical Resection and Treatment Outcomes in Patients with Pulmonary Mucormycosis","volume":"11","author":"Choi","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying Amphotericin B\u2013Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mmcr.2016.04.005","article-title":"Scedosporium Apiospermum Infections and the Role of Combination Antifungal Therapy and GM-CSF: A Case Report and Review of the Literature","volume":"11","author":"Goldman","year":"2016","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.33.9.1647","article-title":"Antifungal Susceptibility of 44 Clinical Isolates of Fusarium Species Determined by Using a Broth Microdilution Method","volume":"33","author":"Reuben","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3389\/fmicb.2019.02196","article-title":"Saprochaete Clavata Invasive Infections\u2014A New Threat to Hematological-Oncological Patients","volume":"10","author":"Buchta","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Vaux, S., Criscuolo, A., Desnos-Ollivier, M., Diancourt, L., Tarnaud, C., Vandenbogaert, M., Brisse, S., Coignard, B., Dromer, F., and Geotrichum Investigation Group (2014). Multicenter Outbreak of Infections by Saprochaete Clavata, an Unrecognized Opportunistic Fungal Pathogen. mBio, 5.","DOI":"10.1128\/mBio.02309-14"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial Use of Combination Treatment Does Not Impact Survival of 106 Patients with Haematologic Malignancies and Mucormycosis: A Propensity Score Analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40121-020-00280-y","article-title":"Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?","volume":"9","author":"Vena","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3201\/eid1910.120847","article-title":"Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","article-title":"The Changing Face of Epidemiology of Invasive Fungal Disease in Europe","volume":"52","year":"2009","journal-title":"Mycoses"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/5\/330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:52:25Z","timestamp":1760161945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/5\/330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["jof7050330"],"URL":"https:\/\/doi.org\/10.3390\/jof7050330","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]}}}